Ctc Enumeration And Characterization As A Pharmacodynamic Marker In The Phase I Clinical Study Of Apx3330, An Ape1/Ref-1 Inhibitor, In Patients With Advanced Solid Tumors.
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要